No CrossRef data available.
Article contents
Recurrent coarctation in Williams syndrome: novel approach of drug-eluting stent implantation
Part of:
Interventional Cardiology
Published online by Cambridge University Press: 16 January 2020
Abstract
Patients with Williams syndrome often present with abnormalities of the vascular wall of the aorta and/or the pulmonary artery. Surgery may result in restenosis of the affected vessel. Herein, we report a case of an infant with multiple recurrences of aortic coarctation successfully treated with Zotarolimus drug-eluting stent.
- Type
- Brief Report
- Information
- Copyright
- © Cambridge University Press 2020
References
Mannarino, S, Collins, RT 2nd. Cardiovascular disease in Williams syndrome. Circulation 2013; 127: 2125–2134.Google Scholar
Collins, RT 2nd, Kaplan, P, Rome, JJ. Stenosis of the thoracic aorta in Williams syndrome. Pediatr Cardiol 2010; 31: 829–833.CrossRefGoogle ScholarPubMed
Mannarino, S, Keizman, E, Pasotti, M, Codazzi, AC, De Sando, E, Giamberti, A. A rare case of discrete aortic coarctation in Williams-Beuren syndrome. Diagnostic and therapeutic considerations. Pediatr Med Chir 2015; 37: pmc.2015.120.CrossRefGoogle ScholarPubMed
Cohen, JL, Glickstein, JS, Crystal, MA. Drug-coated balloon angioplasty: a novel treatment for pulmonary artery in-stent stenosis in a patient with Williams Syndrome. Pediatr Cardiol 2017; 38: 1716–1721.CrossRefGoogle Scholar
Scheinert, D, Duda, S, Zeller, T, et al.The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. J Am Coll Cardiol Cardiovasc Interv 2014; 7: 10–19.10.1016/j.jcin.2013.05.022CrossRefGoogle ScholarPubMed
Palmerini, T, Benedetto, U, Biondi-Zoccai, G, et al.Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 2015; 65: 2496–2507.CrossRefGoogle ScholarPubMed
Lee, KJ, Seto, W, Benson, L, Chaturvedi, RR. Pharmacokinetics of sirolimus-eluting stents implanted in the neonatal arterial duct. Circ Cardiovasc Interv 2015; 8: e002233.doi: 10.1161/CIRCINTERVENTIONS.114.002233CrossRefGoogle ScholarPubMed
Wessely, R, Schomig, A, Kastrati, A. Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different. J Am Coll Cardiol 2006; 47: 708–714.CrossRefGoogle Scholar
Burke, SE, Kuntz, RE, Schwartz, LB. Zotarolimus (ABT-578) eluting stents. Adv Drug Deliv Rev 2006; 58: 437–446.CrossRefGoogle ScholarPubMed
Khan, A, Qureshi, A, Justino, H. Comparison of drug eluting versus bare metal stents for pulmonary vein stenosis in childhood. Catheter Cardiovasc Interv 2019; 94: 233–242.CrossRefGoogle ScholarPubMed